Jump to content

Google-Q&A: Liraglutide outperforms colesevelam in reducing stool frequency in bile acid diarrhea - Healio


Health Reporter
 Share

Recommended Posts

Q&A: Liraglutide outperforms colesevelam in reducing stool frequency in bile acid diarrhea  Healio

Liraglutide reduced stool frequency in a small subset of patients with bile acid diarrhea and warrants consideration as a potential new treatment modality, according to research in The Lancet Gastroenterology and Hepatology.

Researchers aimed to investigate the safety and efficacy of liraglutide, a glucagon-like peptide 1 receptor agonist, in patients with bile acid diarrhea, which is often underdiagnosed and estimated to affect 1% to 2% of the general population.

View the full article


Link to post
Share on other sites

 Share

×
×
  • Create New...